Bibliography
Oosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., Dorpe, J. V., Hellings, P., Gorselink, M., Heymans, S., Theilmeier, G., Dewerchin, M., Laudenbach, V., Vermylen, P., Raat, H., Acker, T., Vleminckx, V., Bosch, L. V. D., Cashman, N., ⦠Carmeliet, P. (2001). Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nature Genetics, 28(2), 131â138.
Authors
32
- Bert Oosthuyse (first)
- Lieve Moons (additional)
- Erik Storkebaum (additional)
- Heike Beck (additional)
- Dieter Nuyens (additional)
- Koen Brusselmans (additional)
- Jo Van Dorpe (additional)
- Peter Hellings (additional)
- Marchel Gorselink (additional)
- Stéphane Heymans (additional)
- Gregor Theilmeier (additional)
- Mieke Dewerchin (additional)
- Vincent Laudenbach (additional)
- Patrick Vermylen (additional)
- Harold Raat (additional)
- Till Acker (additional)
- Vicky Vleminckx (additional)
- Ludo Van Den Bosch (additional)
- Neil Cashman (additional)
- Hajime Fujisawa (additional)
- Maarten R. Drost (additional)
- Raf Sciot (additional)
- Frans Bruyninckx (additional)
- Daniel J Hicklin (additional)
- Can Ince (additional)
- Pierre Gressens (additional)
- Florea Lupu (additional)
- Karl H. Plate (additional)
- Wim Robberecht (additional)
- Jean-Marc Herbert (additional)
- Désiré Collen (additional)
- Peter Carmeliet (additional)
References
46
Referenced
794
-
Carmeliet, P. Mechanisms of angiogenesis and arteriogenesis. Nature Med. 6, 389–395 (2000).
(
10.1038/74651
) / Nature Med. by P Carmeliet (2000) -
Ferrara, N. & Alitalo, K. Clinical applications of angiogenic growth factors and their inhibitors. Nature Med. 5, 1359–1364 (1999).
(
10.1038/70928
) / Nature Med. by N Ferrara (1999) - Miao, H.Q. et al. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J. Cell. Biol. 146, 233–242 (1999). / J. Cell. Biol. by HQ Miao (1999)
-
Soker, S., Takashima, S., Miao, H.Q., Neufeld, G. & Klagsbrun, M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform- specific receptor for vascular endothelial growth factor. Cell 92, 735–745 (1998).
(
10.1016/S0092-8674(00)81402-6
) / Cell by S Soker (1998) -
van Bruggen, N. et al. Vegf antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J. Clin. Invest. 104, 1613–1620 (1999).
(
10.1172/JCI8218
) / J. Clin. Invest. by N van Bruggen (1999) -
Hayashi, T. et al. Expression of angiogenic factors in rabbit spinal cord after transient ischaemia. Neuropathol. Appl. Neurobiol. 25, 63–71 (1999).
(
10.1046/j.1365-2990.1999.00156.x
) / Neuropathol. Appl. Neurobiol. by T Hayashi (1999) -
Schratzberger, P. et al. Favorable effect of Vegf gene transfer on ischemic peripheral neuropathy. Nature Med. 6, 405–413 (2000).
(
10.1038/74664
) / Nature Med. by P Schratzberger (2000) -
Sondell, M., Lundborg, G. & Kanje, M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J. Neurosci. 19, 5731–5740 (1999).
(
10.1523/JNEUROSCI.19-14-05731.1999
) / J. Neurosci. by M Sondell (1999) -
Jin, K.L., Mao, X.O. & Greenberg, D.A. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc. Natl. Acad. Sci. USA 97, 10242–10247 (2000).
(
10.1073/pnas.97.18.10242
) / Proc. Natl. Acad. Sci. USA by KL Jin (2000) -
Dor, Y. & Keshet, E. Ischemia-driven angiogenesis. Trends Cardiovasc. Med. 7, 289–294 (1997).
(
10.1016/S1050-1738(97)00091-1
) / Trends Cardiovasc. Med. by Y Dor (1997) -
Semenza, G.L. Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochem. Pharmacol. 59, 47–53 (2000).
(
10.1016/S0006-2952(99)00292-0
) / Biochem. Pharmacol. by GL Semenza (2000) -
Carmeliet, P. et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435–439 (1996).
(
10.1038/380435a0
) / Nature by P Carmeliet (1996) -
Schultz, A. et al. Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation 100, 547–552 (1999).
(
10.1161/01.CIR.100.5.547
) / Circulation by A Schultz (1999) -
Bromberg, M.B. Pathogenesis of amyotrophic lateral sclerosis: a critical review. Curr. Opin. Neurol. 12, 581–588 (1999).
(
10.1097/00019052-199910000-00012
) / Curr. Opin. Neurol. by MB Bromberg (1999) - Green, S.L. & Tolwani, R.J. Animal models for motor neuron disease. Lab. Anim. Sci. 49, 480–487 (1999). / Lab. Anim. Sci. by SL Green (1999)
- Robberecht, W.L. & de Jong, J.M.B.V. in Amyotrophic Lateral Sclerosis (eds. Brown, R.H.J., Meininger, V. & Swash, M.) 211–222 (Martin Dunitz, London, 2000). / Amyotrophic Lateral Sclerosis by WL Robberecht (2000)
-
Beal, M.F. et al. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 42, 644–654 (1997).
(
10.1002/ana.410420416
) / Ann. Neurol. by MF Beal (1997) -
Ferrante, R.J. et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem. 69, 2064–2074 (1997).
(
10.1046/j.1471-4159.1997.69052064.x
) / J. Neurochem. by RJ Ferrante (1997) -
Marti, H.H. & Risau, W. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc. Natl. Acad. Sci. USA 95, 15809–15814 (1998).
(
10.1073/pnas.95.26.15809
) / Proc. Natl. Acad. Sci. USA by HH Marti (1998) -
Gupta, M., Mungai, P.T. & Goldwasser, E. A new transacting factor that modulates hypoxia-induced expression of the erythropoietin gene. Blood 96, 491–497 (2000).
(
10.1182/blood.V96.2.491
) / Blood by M Gupta (2000) -
Stein, I. et al. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol. Cell. Biol. 18, 3112–3119 (1998).
(
10.1128/MCB.18.6.3112
) / Mol. Cell. Biol. by I Stein (1998) -
Levy, N.S., Chung, S., Furneaux, H. & Levy, A.P. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J. Biol. Chem. 273, 6417–6423 (1998).
(
10.1074/jbc.273.11.6417
) / J. Biol. Chem. by NS Levy (1998) -
Damert, A., Ikeda, E. & Risau, W. Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1- mediated hypoxia-induced transcriptional activation of vascular- endothelial growth factor expression in C6 glioma cells. Biochem. J. 327, 419–423 (1997).
(
10.1042/bj3270419
) / Biochem. J. by A Damert (1997) - Dal Canto, M.C. & Gurney, M.E. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am. J. Pathol. 145, 1271–1279 (1994). / Am. J. Pathol. by MC Dal Canto (1994)
-
Lee, M.K. & Cleveland, D.W. Neuronal intermediate filaments. Annu. Rev. Neurosci. 19, 187–217 (1996).
(
10.1146/annurev.ne.19.030196.001155
) / Annu. Rev. Neurosci. by MK Lee (1996) - Martin, L.J., Price, A.C., Kaiser, A., Shaikh, A.Y. & Liu, Z. Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death. Int. J. Mol. Med. 5, 3–13 (2000). / Int. J. Mol. Med. by LJ Martin (2000)
-
Kawamura, Y., Okazaki, H., O'Brien, P.C. & Dych, P.J. Lumbar motoneurons of man: I) number and diameter histogram of alpha and gamma axons of ventral root. J. Neuropathol. Exp. Neurol. 36, 853–360 (1977).
(
10.1097/00005072-197709000-00009
) / J. Neuropathol. Exp. Neurol. by Y Kawamura (1977) -
Cashman, N.R. et al. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn. 194, 209–221 (1992).
(
10.1002/aja.1001940306
) / Dev. Dyn. by NR Cashman (1992) -
Kong, J. & Xu, Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci. 18, 3241–3250 (1998).
(
10.1523/JNEUROSCI.18-09-03241.1998
) / J. Neurosci. by J Kong (1998) -
Theys, P.A., Peeters, E. & Robberecht, W. Evolution of motor and sensory deficits in amyotrophic lateral sclerosis estimated by neurophysiological techniques. J. Neurol. 246, 438–442 (1999).
(
10.1007/s004150050379
) / J. Neurol. by PA Theys (1999) -
Kostic, V. et al. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann. Neurol. 41, 497–504 (1997).
(
10.1002/ana.410410413
) / Ann. Neurol. by V Kostic (1997) -
Williamson, T.L. et al. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. Proc. Natl. Acad. Sci. USA 95, 9631–9636 (1998).
(
10.1073/pnas.95.16.9631
) / Proc. Natl. Acad. Sci. USA by TL Williamson (1998) -
Ogunshola, O.O. et al. Neuronal Vegf expression correlates with angiogenesis in postnatal developing rat brain. Brain Res. Dev. Brain Res. 119, 139–153 (2000).
(
10.1016/S0165-3806(99)00125-X
) / Brain Res. Dev. Brain Res. by OO Ogunshola (2000) -
Lang-Lazdunski, L. et al. Spinal cord ischemia. Development of a model in the mouse. Stroke 31, 208–213 (2000).
(
10.1161/01.STR.31.1.208
) / Stroke by L Lang-Lazdunski (2000) -
Nohl, H., Staniek, K. & Gille, L. Imbalance of oxygen activation and energy metabolism as a consequence or mediator of aging. Exp. Gerontol. 32, 485–500 (1997).
(
10.1016/S0531-5565(96)00169-6
) / Exp. Gerontol. by H Nohl (1997) -
Ochiai-Kanai, R., Hasegawa, K., Takeuchi, Y., Yoshioka, H. & Sawada, T. Immunohistochemical nitrotyrosine distribution in neonatal rat cerebrocortical slices during and after hypoxia. Brain Res. 847, 59–70 (1999).
(
10.1016/S0006-8993(99)02020-X
) / Brain Res. by R Ochiai-Kanai (1999) - Knight, J.A. Reactive oxygen species and the neurodegenerative disorders. Ann. Clin. Lab. Sci. 27, 11–25 (1997). / Ann. Clin. Lab. Sci. by JA Knight (1997)
-
Rivard, A. et al. Age-dependent defect in VEGF expression is associated with reduced HIF1a activity. J. Biol. Chem. 275, 29643–29647 (2000).
(
10.1074/jbc.M001029200
) / J. Biol. Chem. by A Rivard (2000) -
Hellwig-Burgel, T., Rutkowski, K., Metzen, E., Fandrey, J. & Jelkmann, W. Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 94, 1561–1567 (1999).
(
10.1182/blood.V94.5.1561
) / Blood by T Hellwig-Burgel (1999) -
He, Z. & Tessier-Lavigne, M. Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 90, 739–751 (1997).
(
10.1016/S0092-8674(00)80534-6
) / Cell by Z He (1997) -
Yu, H.H. & Kolodkin, A.L. Semaphorin signaling: a little less per-plexin. Neuron 22, 11–14 (1999).
(
10.1016/S0896-6273(00)80672-8
) / Neuron by HH Yu (1999) -
Raper, J.A. Semaphorins and their receptors in vertebrates and invertebrates. Curr. Opin. Neurobiol. 10, 88–94 (2000).
(
10.1016/S0959-4388(99)00057-4
) / Curr. Opin. Neurobiol. by JA Raper (2000) -
Plate, K.H., Beck, H., Danner, S., Allegrini, P.R. & Wiessner, C. Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct. J. Neuropathol. Exp. Neurol. 58, 654–666 (1999).
(
10.1097/00005072-199906000-00010
) / J. Neuropathol. Exp. Neurol. by KH Plate (1999) -
Carmeliet, P. et al. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nature Med. 5, 495–502 (1999).
(
10.1038/8379
) / Nature Med. by P Carmeliet (1999) -
Gorselink, M. et al. Accurate measurements of in situ isometric contractile properties of hind limb plantar and dorsal flexor muscle complex of intact mice. Eur. J. Physiol. 439, 665–670 (2000).
(
10.1007/s004249900208
) / Eur. J. Physiol. by M Gorselink (2000) -
Vandenberghe, W., Van Den Bosch, L. & Robberecht, W. Glial cells potentiate kainate-induced neuronal death in a motoneuron- enriched spinal coculture system. Brain Res. 807, 1–10 (1998).
(
10.1016/S0006-8993(98)00569-1
) / Brain Res. by W Vandenberghe (1998)
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 26, 2002, 4:43 a.m.) |
Deposited | 2 years, 3 months ago (May 18, 2023, 4:38 p.m.) |
Indexed | 4 days, 7 hours ago (Aug. 27, 2025, 11:36 a.m.) |
Issued | 24 years, 2 months ago (June 1, 2001) |
Published | 24 years, 2 months ago (June 1, 2001) |
Published Print | 24 years, 2 months ago (June 1, 2001) |
@article{Oosthuyse_2001, title={Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration}, volume={28}, ISSN={1546-1718}, url={http://dx.doi.org/10.1038/88842}, DOI={10.1038/88842}, number={2}, journal={Nature Genetics}, publisher={Springer Science and Business Media LLC}, author={Oosthuyse, Bert and Moons, Lieve and Storkebaum, Erik and Beck, Heike and Nuyens, Dieter and Brusselmans, Koen and Dorpe, Jo Van and Hellings, Peter and Gorselink, Marchel and Heymans, Stéphane and Theilmeier, Gregor and Dewerchin, Mieke and Laudenbach, Vincent and Vermylen, Patrick and Raat, Harold and Acker, Till and Vleminckx, Vicky and Bosch, Ludo Van Den and Cashman, Neil and Fujisawa, Hajime and Drost, Maarten R. and Sciot, Raf and Bruyninckx, Frans and Hicklin, Daniel J and Ince, Can and Gressens, Pierre and Lupu, Florea and Plate, Karl H. and Robberecht, Wim and Herbert, Jean-Marc and Collen, Désiré and Carmeliet, Peter}, year={2001}, month=jun, pages={131–138} }